Skip to Content

Azatadine Pregnancy and Breastfeeding Warnings

Azatadine is also known as: Optimine

Azatadine Pregnancy Warnings

In a review of 229,101 deliveries to Michigan Medicaid patients, 127 first-trimester exposures to azatadine and 1311 exposures anytime during pregnancy were recorded. A total of six birth defects were reported with first trimester exposure (5 expected) and included one oral clefts and one limb reduction. (written communication, Franz Rosa, MD, Food and Drug Administration, 1994) These data do not support an association between azatadine and birth defects. A review of prenatal drug use in 3026 women with premature infants demonstrated an increased risk of retrolental fibroplasia with antihistamine use during the last two weeks of pregnancy. The dosage used or the particular antihistamine was not specified. The incidence of retrolental fibroplasia in premature infants exposed in utero to antihistamine during this time was 21% compared to 11% in premature infants not exposed.

Azatadine has been assigned to pregnancy category B by the FDA. Animal studies at higher than recommended doses have revealed no evidence of fetal harm. There are no controlled data in human pregnancy. Azatadine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Azatadine Breastfeeding Warnings

There are no data on the excretion of azatadine into human milk.

See references

References for pregnancy information

  1. "Product Information. Optimine (azatadine)." Schering Laboratories, Kenilworth, NJ.
  2. Zierler S, Purohit D "Prenatal antihistamine exposure and retrolental fibroplasia." Am J Epidemiol 123 (1986): 192-6

References for breastfeeding information

  1. "Product Information. Optimine (azatadine)." Schering Laboratories, Kenilworth, NJ.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.